持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/01/23 | 6,480 | 6,480 | 6,360 | 6,380 | -110 | -1.7% | 28,900 |
2014/01/22 | 6,470 | 6,500 | 6,410 | 6,490 | +30 | +0.5% | 18,600 |
2014/01/21 | 6,450 | 6,470 | 6,400 | 6,460 | +20 | +0.3% | 20,500 |
2014/01/20 | 6,380 | 6,470 | 6,360 | 6,440 | +70 | +1.1% | 22,200 |
2014/01/17 | 6,300 | 6,390 | 6,250 | 6,370 | +40 | +0.6% | 29,700 |
2014/01/16 | 6,290 | 6,370 | 6,240 | 6,330 | +70 | +1.1% | 34,300 |
2014/01/15 | 6,220 | 6,270 | 6,170 | 6,260 | +60 | +1% | 25,800 |
2014/01/14 | 6,230 | 6,230 | 6,120 | 6,200 | +10 | +0.2% | 36,900 |
2014/01/10 | 6,210 | 6,210 | 6,110 | 6,190 | +10 | +0.2% | 45,600 |
2014/01/09 | 6,180 | 6,190 | 6,120 | 6,180 | -10 | -0.2% | 39,600 |
2014/01/08 | 6,190 | 6,190 | 6,110 | 6,190 | +20 | +0.3% | 22,900 |
2014/01/07 | 6,120 | 6,190 | 6,120 | 6,170 | ±0 | ±0% | 25,500 |
2014/01/06 | 6,250 | 6,250 | 6,110 | 6,170 | -80 | -1.3% | 40,100 |
2013/12/30 | 6,200 | 6,320 | 6,180 | 6,250 | +150 | +2.5% | 49,500 |
2013/12/27 | 6,020 | 6,100 | 5,940 | 6,100 | +140 | +2.3% | 37,000 |
2013/12/26 | 5,770 | 5,970 | 5,770 | 5,960 | +250 | +4.4% | 25,100 |
2013/12/25 | 5,750 | 5,750 | 5,690 | 5,710 | -60 | -1% | 31,600 |
2013/12/24 | 5,840 | 5,870 | 5,770 | 5,770 | -110 | -1.9% | 20,400 |
2013/12/20 | 5,920 | 5,920 | 5,850 | 5,880 | -90 | -1.5% | 36,500 |
2013/12/19 | 5,890 | 5,970 | 5,890 | 5,970 | +80 | +1.4% | 58,700 |
2013/12/18 | 5,890 | 5,940 | 5,850 | 5,890 | -50 | -0.8% | 50,400 |
2013/12/17 | 5,800 | 5,940 | 5,800 | 5,940 | +160 | +2.8% | 52,700 |
2013/12/16 | 5,940 | 5,960 | 5,780 | 5,780 | -60 | -1% | 49,500 |
2013/12/13 | 5,910 | 5,910 | 5,810 | 5,840 | -110 | -1.8% | 97,800 |
2013/12/12 | 6,000 | 6,000 | 5,940 | 5,950 | -60 | -1% | 38,600 |
2013/12/11 | 6,050 | 6,050 | 5,980 | 6,010 | -20 | -0.3% | 43,100 |
2013/12/10 | 6,090 | 6,090 | 6,020 | 6,030 | -50 | -0.8% | 31,300 |
2013/12/09 | 6,080 | 6,090 | 6,030 | 6,080 | +70 | +1.2% | 27,500 |
2013/12/06 | 6,010 | 6,030 | 5,940 | 6,010 | ±0 | ±0% | 44,500 |
2013/12/05 | 6,030 | 6,060 | 6,010 | 6,010 | -50 | -0.8% | 30,900 |
2013/12/04 | 6,080 | 6,140 | 6,020 | 6,060 | -30 | -0.5% | 49,000 |
2013/12/03 | 6,130 | 6,150 | 6,090 | 6,090 | -50 | -0.8% | 31,100 |
2013/12/02 | 6,150 | 6,180 | 6,140 | 6,140 | ±0 | ±0% | 17,100 |
2013/11/29 | 6,200 | 6,220 | 6,110 | 6,140 | -90 | -1.4% | 17,700 |
2013/11/28 | 6,250 | 6,250 | 6,190 | 6,230 | +20 | +0.3% | 15,000 |
2013/11/27 | 6,220 | 6,240 | 6,190 | 6,210 | -10 | -0.2% | 14,600 |
2013/11/26 | 6,250 | 6,250 | 6,200 | 6,220 | -10 | -0.2% | 16,100 |
2013/11/25 | 6,170 | 6,230 | 6,130 | 6,230 | +50 | +0.8% | 21,700 |
2013/11/22 | 6,290 | 6,290 | 6,160 | 6,180 | -70 | -1.1% | 22,700 |
2013/11/21 | 6,200 | 6,250 | 6,170 | 6,250 | +90 | +1.5% | 27,500 |
2013/11/20 | 6,130 | 6,170 | 6,100 | 6,160 | +40 | +0.7% | 21,400 |
2013/11/19 | 6,130 | 6,180 | 6,090 | 6,120 | -50 | -0.8% | 24,000 |
2013/11/18 | 6,150 | 6,230 | 6,140 | 6,170 | +40 | +0.7% | 19,900 |
2013/11/15 | 6,210 | 6,240 | 6,130 | 6,130 | -50 | -0.8% | 46,700 |
2013/11/14 | 6,130 | 6,230 | 6,110 | 6,180 | +50 | +0.8% | 37,200 |
2013/11/13 | 6,290 | 6,300 | 6,080 | 6,130 | -160 | -2.5% | 53,600 |
2013/11/12 | 6,260 | 6,290 | 6,220 | 6,290 | +20 | +0.3% | 29,000 |
2013/11/11 | 6,240 | 6,280 | 6,140 | 6,270 | +110 | +1.8% | 37,600 |
2013/11/08 | 6,110 | 6,190 | 6,110 | 6,160 | -30 | -0.5% | 16,700 |
2013/11/07 | 6,250 | 6,250 | 6,130 | 6,190 | -70 | -1.1% | 35,700 |
2651~
2700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム